New study aims to improve counseling for parents facing rare fetal tumor
NCT ID NCT04623658
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks back at 84 cases of sacrococcygeal teratoma, a rare tumor in fetuses and infants. Researchers want to find factors that predict how the tumor will behave, whether it will come back, and what long-term effects it may have. The goal is to give parents clearer information when the tumor is found during pregnancy.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors give better information to parents when a sacrococcygeal teratoma is found during pregnancy.
- What could go wrong
- This is a retrospective study that looks back at past cases, so it cannot prove cause and effect. The findings may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
84 people
The number who actually took part.
- Started
-
Nov 2020
- Finished
-
Apr 2021
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Fetuses and infants diagnosed with sacrococcygeal teratoma and cared for between 2007 and 2017 in the main Parisian fetal medicine and pediatric surgery units: Necker-Enfants Malades Hospital, Antoine Béclère Hospital, Armand Trousseau Hospital, Robert Debré Hospital and Le Kremlin-Bicêtre Hospital.
- Ages
-
Up to 10 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Fetuses and infants (\< 1 year) diagnosed with benign sacrococcygeal teratoma * Cared for between January 2007 and December 2017 in the participating centers Exclusion Criteria: * Currarino syndrome * Other benign sacrococcygeal teratoma discovered after 1 year old or malignant sacrococcygeal tumors
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Sacrococcygeal teratoma are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Necker-Enfants Malades Hospital
Paris, 75015, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.